Most of the special expression molecules of different subtypes in the table are used for breast cancer typing, such as the expression of GENES and proteins related to K67 and HR, while other molecules that are different from the expression of HER2-E can serve as potential targets for the treatment of HER2-negative breast cancer (9–11). Here, ERBB2 is linked to breast carcinoma.